Repotrectinib (TPX-0005)
TPX-0005-01
Phase 2 small_molecule active
Quick answer
Repotrectinib (TPX-0005) for Advanced Solid Tumors is a Phase 2 program (small_molecule) at Turn Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Turn Therapeutics
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active